Business

Zealand Pharma to participate in upcoming investor conferences in September 2025

Press release – No. 12 / 2025 Zealand Pharma to participate in upcoming investor conferences in September 2025 Copenhagen, Denmark, August 28, 2025 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced that the company will participate in the following investor conferences in September 2025. Jefferies Swiss Healthcare Summit 2025, September 3 in Zürich Adam Lange, Vice Presid

articleZealand Pharma A/sAugust 28, 20252/company/zealand-pharma-as-1/news/zealand-pharma-to-participate-in-upcoming-investor-conferences-in-september-2025
Zealand Pharma to participate in upcoming investor conferences in September 2025

About this update from Zealand Pharma A/s

[{"type":"image","alt":"Zealand Pharma","displaySize":"","headline":null,"caption":"Zealand Pharma","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":121,"url":"https://media.zenfs.com/en/globenewswire.com/2567d307984f8639b4a7711f51c64eff"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/6gUCOEdJjLHihlE.VvDQtA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE2OTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/2567d307984f8639b4a7711f51c64eff","width":300,"height":121}},"lazy":false},{"type":"text","content":"Press release – No. 12 / 2025","length":29,"tagName":"p"},{"type":"text","content":"Zealand Pharma to participate in upcoming investor conferences in September 2025","length":80,"tagName":"p"},{"type":"text","content":"Copenhagen, Denmark, August 28, 2025 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced that the company will participate in the following investor conferences in September 2025.","length":303,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Jefferies Swiss Healthcare Summit 2025, September 3 in Zürich","length":61,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":61,"olType":false},{"type":"text","content":"Adam Lange, Vice President, Investor Relations, will host investor meetings on Wednesday, September 3.","length":102,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Cantor Global Healthcare Conference 2025, September 3-5 in New York","length":67,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":67,"olType":false},{"type":"text","content":"Adam Steensberg, President and Chief Executive Officer will host investor meetings on Thursday, September 4 and participate in a fireside chat at 8:00am EDT (14:00pm CET).","length":171,"tagName":"p"},{"type":"text","content":"A live audio webcast of the fireside chat will be available at https://sqps.onstreamsecure.com/origin/enliven/players/EnlivenPlayer.html?customerId=22&eventId=18684721&checkCompany=1&checkEmail=1&checkName=1. A replay of the webcast will be available at https://www.zealandpharma.com/events/.","length":313,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"2025 Wells Fargo Healthcare Conference, September 3-...

More updates from Zealand Pharma A/s

Zealand PharmaAdam LangeInvestor RelationsVice PresidentCantor Global Healthcare ConferenceHealthcare Conferencebiotechnology companyfireside chatAdam Steensberg